Chronic automated red cell exchange therapy for sickle cell disease.

Abdulhafiz ZakiehNicolas Mercure-CorriveauSophie LanzkronXinyi FengSonja VozniakElizabeth P CroweHerleen RaiCourtney LawrenceDenise BekkouriRuchika GoelAaron A R Tobian Evan M Bloch

Published in: Transfusion (2024)

Prospective clinical trials are needed to determine which patients are most likely to benefit from chronic RCE and refine selection accordingly.

Keyphrases

sickle cell disease
clinical trial
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
single cell
machine learning
deep learning
cell therapy
patient reported outcomes
drug induced
bone marrow
patient reported
study protocol